To assess the effect of two days injectable dexamethasone therapy in resolution of uncomplicated parapneumonic effusion in hospitalized children aged 1month to 14years
Not Applicable
- Conditions
- Health Condition 1: J681- Pulmonary edema due to chemicals,gases, fumes and vapors
- Registration Number
- CTRI/2021/03/032169
- Lead Sponsor
- Department of Paediatrics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children aged 1mo-14years
1Children admitted for pneumonia with uncomplicated parapneumonic effusion confirmed by bedside ultrasonography
2Patients whose parents give consent for participation
Exclusion Criteria
•Immmune deficiency state
•Malignancy
•Fluid collection due to congestive heart failure,nephrotic syndrome,liver disease and tuberculosis
•Patients with complicated pleural effusion
•Patients with hemodynamic/respiratory instability requiring intensive care
•Patients taking steroids in any form due to any disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of two days injectable dexamethasone therapy in resolution of uncomplicated parapneumonic effusion that is the decrease in quantity of parapneumonic effusion after two days of injectable Dexamethasone therapy in hospitalized children aged 1month-14years as defined by bedside ultrasonographyTimepoint: To assess the effect of two days injectable dexamethasone therapy in resolution of uncomplicated parapneumonic effusion that is the decrease in quantity of parapneumonic effusion after two days of injectable dexamethasone therapy in hospitalized children aged 1month-14years as defined by bedside ultrasonography
- Secondary Outcome Measures
Name Time Method â?¢To determine change in CRP level 72hrs after initiation of dexamethasone therapy.Timepoint: 72 hours